Gert De Beckker

Gert De Beckker is a biopharmaceutical executive with more than 25 years of experience in global regulatory affairs and drug development. Prior to joining Coultreon, he served as Vice President and Head of Regulatory Affairs at Galapagos, where he led regulatory strategy across the full product lifecycle and advised executive leadership on portfolio, development, and transaction decisions. Earlier in his career, he held various regulatory roles at TiGenix, Schering‑Plough, and Pharmacia & Upjohn.

Gert has a strong track record of successful interactions with major health authorities, including the FDA, EMA, MHRA, Swissmedic, PMDA, and EU national agencies. He has played a key role in numerous INDs, CTAs, and global marketing authorizations across small‑molecule medicines and advanced therapies.

He holds a Master's degree in Biology from Ghent University and a postgraduate degree in Environmental Impact Assessment from KU Leuven. Gert is recognized for sound judgment, effective execution in complex environments, and scalable leadership.